Literature DB >> 14559792

p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis.

Daniel Medina1, Frances S Kittrell.   

Abstract

Limited hormonal stimulation of the mammary gland during a critical window in postpubertal development imparts a long-lasting protective effect against breast cancer in humans and in rodent models. The hormonal stimulation can be achieved by full-term pregnancy or low doses of estradiol-17beta and progesterone administered for 21 days. The mechanism(s) behind this effect of hormones is not understood at the molecular level. The experiments reported here demonstrate that the absence of p53 tumor suppressor gene function abrogates the protective effect of hormones against carcinogen-induced mammary carcinogenesis in BALB/c mice. This is the first identification of a specific gene product that mediates the protective effect of hormones. Additionally, the experiments highlight the usefulness of transgenic mouse models in the testing of hypotheses derived from the classic rat mammary models.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559792

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

1.  Aryl hydrocarbon receptor activation during pregnancy, and in adult nulliparous mice, delays the subsequent development of DMBA-induced mammary tumors.

Authors:  Tao Wang; Heather M Gavin; Volker M Arlt; B Paige Lawrence; Suzanne E Fenton; Daniel Medina; Beth A Vorderstrasse
Journal:  Int J Cancer       Date:  2010-06-02       Impact factor: 7.396

Review 2.  Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.

Authors:  Viroj Boonyaratanakornkit; Nalo Hamilton; Diana C Márquez-Garbán; Prangwan Pateetin; Eileen M McGowan; Richard J Pietras
Journal:  Mol Cell Endocrinol       Date:  2017-11-14       Impact factor: 4.102

3.  Pathways contributing to development of spontaneous mammary tumors in BALB/c-Trp53+/- mice.

Authors:  Haoheng Yan; Anneke C Blackburn; S Christine McLary; Luwei Tao; Amy L Roberts; Elizabeth A Xavier; Ellen S Dickinson; Jae Hong Seo; Richard B Arenas; Christopher N Otis; Qing J Cao; Rebecca G Lawlor; Barbara A Osborne; Frances S Kittrell; Daniel Medina; D Joseph Jerry
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

Review 4.  Pregnancy-induced changes in breast cancer risk.

Authors:  Irma H Russo; Jose Russo
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-09       Impact factor: 2.673

Review 5.  Estrogens, regulation of p53 and breast cancer risk: a balancing act.

Authors:  D Joseph Jerry; Karen A Dunphy; Mary J Hagen
Journal:  Cell Mol Life Sci       Date:  2010-04       Impact factor: 9.261

6.  Apoptosis and tumor inhibition induced by human chorionic gonadotropin beta in mouse breast carcinoma.

Authors:  Shu-Qun Shi; Li Xu; Gang Zhao; Ying Yang; Jing-Pian Peng
Journal:  J Mol Med (Berl)       Date:  2006-08-05       Impact factor: 4.599

7.  Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia.

Authors:  Edgar S Díaz-Cruz; Priscilla A Furth
Journal:  Cancer Res       Date:  2010-05-15       Impact factor: 12.701

8.  Altered mammary gland development in the p53+/m mouse, a model of accelerated aging.

Authors:  Catherine E Gatza; Melissa Dumble; Frances Kittrell; David G Edwards; Robert K Dearth; Adrian V Lee; Jianming Xu; Daniel Medina; Lawrence A Donehower
Journal:  Dev Biol       Date:  2007-10-12       Impact factor: 3.582

9.  Decreasing hormonal promotion is key to breast cancer prevention.

Authors:  Lakshmanaswamy Rajkumar; Amy Canada; David Esparza; Katherine Collins; Enrique Moreno; Huyen Duong
Journal:  Endocrine       Date:  2009-02-12       Impact factor: 3.633

10.  Identification of novel amplification gene targets in mouse and human breast cancer at a syntenic cluster mapping to mouse ch8A1 and human ch13q34.

Authors:  Martin C Abba; Victoria T Fabris; Yuhui Hu; Frances S Kittrell; Wei-Wen Cai; Lawrence A Donehower; Aysegul Sahin; Daniel Medina; C Marcelo Aldaz
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.